Attached files

file filename
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10kexh322.txt
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10kexh312.txt
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10kexh321.txt
EX-10.19 - LEASE AGREEMENT BETWEEN FULLERTON BUSINESS CENTER, LLC, LESSOR, AND ALLIED MED, INC., LESSEE, DATED NOVEMBER 9, 2009 - AMEXDRUG CORPamrx10k20091231ex10-19.htm
EX-10.20 - THIRD AMENDMENT TO LEASE AGREEMENT BETWEEN FULLERTON BUSINESS CENTER, LESSOR, AND ALLIED MED, INC., LESSEE, DATED NOVEMBER 5, 2008 - AMEXDRUG CORPamrx10k20091231ex10-20.htm
10-K - AMEXDRUG CORPORATION FORM 10-K DECEMBER 31, 2009 - AMEXDRUG CORPamexdrug10k.txt

================================================================================

                                  EXHIBIT 31.1

                                  SECTION 302
                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER


      I, Jack Amin, chief executive officer of Amexdrug Corporation (the
"registrant"), certify that:

      1. I have reviewed this annual report on Form 10-K of Amexdrug
Corporation;

      2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

      3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

      4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:

            (a)   designed such disclosure controls and procedures, or caused
                  such disclosure controls and procedures to be designed under
                  our supervision, to ensure that material information relating
                  to the registrant, including its consolidated subsidiaries, is
                  made known to us by others within those entities, particularly
                  during the period in which this report is being prepared;

            (b)   designed such internal control over financial reporting, or
                  caused such internal control over financial reporting to be
                  designed under our supervision, to provide reasonable
                  assurance regarding the reliability of financial reporting and
                  the preparation of financial statements for external purposes
                  in accordance with generally accepted accounting principles;

            (c)   evaluated the effectiveness of the registrant's disclosure
                  controls and procedures and presented in this report our
                  conclusions about the effectiveness of the disclosure controls
                  and procedures, as of the end of the period covered by this
                  report based on such evaluation; and

            (d)   disclosed in this report any change in the registrant's
                  internal control over financial reporting that occurred during
                  the registrant's most recent fiscal quarter (the registrant's
                  fourth fiscal quarter in the case of an annual report) that
                  has materially affected, or is reasonably likely to materially
                  affect, the registrant's internal control over financial
                  reporting; and

      5. The registrant's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent
functions):

            (a)   all significant deficiencies and material weaknesses in the
                  design or operation of internal control over financial
                  reporting which are reasonably likely to adversely affect the
                  registrant's ability to record, process, summarize and report
                  financial information; and

            (b)   any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  registrant's internal control over financial reporting.



Date: March 30, 2010             By /s/ Jack Amin_
                                    ----------------------------------
                                    Jack Amin, Chief Executive Officer



-------------------------------------------------------------------------------